AIMZERI Trademark
Trademark Overview
On Thursday, October 9, 2025, a trademark application was filed for AIMZERI with the United States Patent and Trademark Office. The USPTO has given the AIMZERI trademark a serial number of 99435352. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, April 29, 2026. This trademark is owned by Pfizer Inc.. The AIMZERI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorder; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes
General Information
| Serial Number | 99435352 |
| Word Mark | AIMZERI |
| Filing Date | Thursday, October 9, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, April 29, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorder; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 9, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10001-2192
US |
Trademark Events
| Event Date | Event Description |
| Thursday, October 9, 2025 | NEW APPLICATION ENTERED |
| Thursday, October 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 30, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, January 30, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 30, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 30, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, February 4, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, February 4, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 4, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 4, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 28, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 28, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 28, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 29, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
